Product Code: GVR-4-68038-727-8
Endotracheal Tube Market Growth & Trends:
The global endotracheal tube market size is estimated to reach USD 2.92 billion by 2030, registering a CAGR of 6.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers expected to contribute to market growth include an increase in disease burden, constant increase in the number of surgeries being undertaken worldwide, technological advancements, and increase in private & public healthcare expenditure.
The increased prevalence of respiratory disorders and rising technological development in the field of endotracheal tubes are factors anticipated to boost the market growth. Rapid innovations in endotracheal tubes have increased the need for medical device companies to incorporate new technologies in their products to maintain market demand. An increase in product complexity, and the availability of newer types of endotracheal tubes, are some factors increasing the demand for endotracheal tubes.
Companies operating in the endotracheal tube industry are adopting various strategies, such as new product launches, regional expansion, and partnerships & collaborations, to gain higher market shares. For instance, in May 2021, Medtronic plc, announced the commercial launch of the airway monitoring SonarMedTM system in the U.S. The airway monitoring SonarMed system, the only and first device of its kind, uses acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time, providing clinicians with vital information needed to make life-saving, and more informed decisions for their smallest patients. This is expected to drive growth in the endotracheal tube industry in near future.
Endotracheal Tube Market Report Highlights:
- Based on product, the regular endotracheal tube segment dominated the market and held the largest revenue share of 32.17% in 2024. Most medical device companies are focusing on developing advanced technologies due to the high prevalence of respiratory diseases, which is likely to boost the segment growth.
- Based on route, the orotracheal segment dominated the market and held the largest revenue share in 2024. The orotracheal tubes industry is estimated to grow in near future due to increasing cases of chronic disease and lung infection.
- Based on application, the emergency treatment segment held the largest market share in 2024. Further, the emergency treatment segment is estimated to grow extensively in the near future, due to factors such as increasing cases of road accidents, rising geriatric population, and increasing cases of ventilator-associated pneumonia.
- North America held the highest share of the global market, accounting for 34.54% of the share in 2024. Rapid growth in the manufacturing of endotracheal tubes to meet the high demand for efficient healthcare in the region is expected to be one of the major factors contributing to market growth.
- Asia Pacific is anticipated to witness fastest CAGR during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, & improved regulatory framework.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of Primary Research
- 1.5.1. Data for Primary Interviews in North America
- 1.5.2. Data for Primary Interviews in Europe
- 1.5.3. Data for Primary Interviews in Asia Pacific
- 1.5.4. Data for Primary Interviews in Latin America
- 1.5.5. Data for Primary Interviews in MEA
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity Flow Approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume Price Analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Endotracheal Tube Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Increasing Prevalence of Chronic Conditions
- 3.2.1.2. Technologically Advanced Equipment
- 3.2.1.3. Rising Geriatric Population
- 3.2.1.4. Increase in the Number of Surgeries
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. High Risk of Postsurgical Complications due to Endotracheal Intubation
- 3.2.2.2. Product Recalls
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Endotracheal Tube Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining Power of the Suppliers
- 3.3.1.2. Bargaining Power of the Buyers
- 3.3.1.3. Threats of Substitution
- 3.3.1.4. Threats From New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological Landscape
- 3.3.2.4. Environmental Landscape
- 3.3.2.5. Legal Landscape
Chapter 4. Endotracheal Tube Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. Product Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. Endotracheal Tube Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
- 4.6. Regular Endotracheal Tube
- 4.6.1. Regular Endotracheal Tube Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Reinforced Endotracheal Tube
- 4.7.1. Reinforced Endotracheal Tube Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Preformed Endotracheal Tube
- 4.8.1. Preformed Endotracheal Tube Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9. Double-lumen Endotracheal Tube
- 4.9.1. Double-lumen Endotracheal Tube Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Endotracheal Tube Market: Route Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. Route Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. Endotracheal Tube Market by Route Outlook
- 5.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
- 5.6. Orotracheal
- 5.6.1. Orotracheal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Nasotracheal
- 5.7.1. Nasotracheal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Endotracheal Tube Market: Application Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. Application Market Share, 2018 & 2030
- 6.3. Segment Dashboard
- 6.4. Endotracheal Tube Market by Application Outlook
- 6.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
- 6.6. Emergency Treatment
- 6.6.1. Emergency Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Therapy
- 6.7.1. Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Endotracheal Tube Market: End Use Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.2. End Use Market Share, 2018 & 2030
- 7.3. Segment Dashboard
- 7.4. Endotracheal Tube Market by End Use Outlook
- 7.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
- 7.6. Hospitals
- 7.6.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Clinics
- 7.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Ambulatory Surgical Centers
- 7.8.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Others
- 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Endotracheal Tube Market: Regional Estimates & Trend Analysis, By Product
- 8.1. Regional market share analysis, 2024 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Regional Market Share and Leading Players, 2024
- 8.4.1. North America
- 8.4.2. Europe
- 8.4.3. Asia Pacific
- 8.4.4. Latin America
- 8.4.5. Middle East and Africa
- 8.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030:
- 8.6. Endotracheal Tube Market Share, By Region, 2024 & 2030 (USD Million)
- 8.7. North America
- 8.7.1. North America Endotracheal Tube Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. U.S.
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. Reimbursement Scenario
- 8.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
- 8.7.3. Canada
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Reimbursement Scenario
- 8.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
- 8.7.4. Mexico
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. Reimbursement Scenario
- 8.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
- 8.8. Europe
- 8.8.1. Europe Endotracheal Tube Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. UK
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Reimbursement Scenario
- 8.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
- 8.8.3. Germany
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Reimbursement Scenario
- 8.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
- 8.8.4. France
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Competitive Scenario
- 8.8.4.3. Regulatory Framework
- 8.8.4.4. Reimbursement Scenario
- 8.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
- 8.8.5. Italy
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Competitive Scenario
- 8.8.5.3. Regulatory Framework
- 8.8.5.4. Reimbursement Scenario
- 8.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
- 8.8.6. Spain
- 8.8.6.1. Key Country Dynamics
- 8.8.6.2. Competitive Scenario
- 8.8.6.3. Regulatory Framework
- 8.8.6.4. Reimbursement Scenario
- 8.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
- 8.8.7. Denmark
- 8.8.7.1. Key Country Dynamics
- 8.8.7.2. Competitive Scenario
- 8.8.7.3. Regulatory Framework
- 8.8.7.4. Reimbursement Scenario
- 8.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
- 8.8.8. Sweden
- 8.8.8.1. Key Country Dynamics
- 8.8.8.2. Competitive Scenario
- 8.8.8.3. Regulatory Framework
- 8.8.8.4. Reimbursement Scenario
- 8.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
- 8.8.9. Norway
- 8.8.9.1. Key Country Dynamics
- 8.8.9.2. Competitive Scenario
- 8.8.9.3. Regulatory Framework
- 8.8.9.4. Reimbursement Scenario
- 8.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
- 8.9. Asia Pacific
- 8.9.1. Asia Pacific Endotracheal Tube Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.9.2. China
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Competitive Scenario
- 8.9.2.3. Regulatory Framework
- 8.9.2.4. Reimbursement Scenario
- 8.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
- 8.9.3. India
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Competitive Scenario
- 8.9.3.3. Regulatory Framework
- 8.9.3.4. Reimbursement Scenario
- 8.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
- 8.9.4. Japan
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Competitive Scenario
- 8.9.4.3. Regulatory Framework
- 8.9.4.4. Reimbursement Scenario
- 8.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
- 8.9.5. South Korea
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Competitive Scenario
- 8.9.5.3. Regulatory Framework
- 8.9.5.4. Reimbursement Scenario
- 8.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
- 8.9.6. Thailand
- 8.9.6.1. Key Country Dynamics
- 8.9.6.2. Competitive Scenario
- 8.9.6.3. Regulatory Framework
- 8.9.6.4. Reimbursement Scenario
- 8.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
- 8.9.7. Australia
- 8.9.7.1. Key Country Dynamics
- 8.9.7.2. Competitive Scenario
- 8.9.7.3. Regulatory Framework
- 8.9.7.4. Reimbursement Scenario
- 8.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
- 8.10. Latin America
- 8.10.1. Latin America Endotracheal Tube Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.10.2. Brazil
- 8.10.2.1. Key Country Dynamics
- 8.10.2.2. Competitive Scenario
- 8.10.2.3. Regulatory Framework
- 8.10.2.4. Reimbursement Scenario
- 8.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
- 8.10.3. Argentina
- 8.10.3.1. Key Country Dynamics
- 8.10.3.2. Competitive Scenario
- 8.10.3.3. Regulatory Framework
- 8.10.3.4. Reimbursement Scenario
- 8.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
- 8.11. Middle East and Africa
- 8.11.1. Middle East and Africa Endotracheal Tube Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.11.2. South Africa
- 8.11.2.1. Key Country Dynamics
- 8.11.2.2. Competitive Scenario
- 8.11.2.3. Regulatory Framework
- 8.11.2.4. Reimbursement Scenario
- 8.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
- 8.11.3. Saudi Arabia
- 8.11.3.1. Key Country Dynamics
- 8.11.3.2. Competitive Scenario
- 8.11.3.3. Regulatory Framework
- 8.11.3.4. Reimbursement Scenario
- 8.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
- 8.11.4. UAE
- 8.11.4.1. Key Country Dynamics
- 8.11.4.2. Competitive Scenario
- 8.11.4.3. Regulatory Framework
- 8.11.4.4. Reimbursement Scenario
- 8.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
- 8.11.5. Kuwait
- 8.11.5.1. Key Country Dynamics
- 8.11.5.2. Competitive Scenario
- 8.11.5.3. Regulatory Framework
- 8.11.5.4. Reimbursement Scenario
- 8.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors
- 9.3.2. Key Company Market Share Analysis, 2024
- 9.4. Key Company Profiles
- 9.4.1. Angiplast Pvt Ltd
- 9.4.1.1. Participant's Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Advin Health Care
- 9.4.2.1. Participant's Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Sterimed Group
- 9.4.3.1. Participant's Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. ICU Medical, Inc.
- 9.4.4.1. Participant's Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Medtronic (Covidien)
- 9.4.5.1. Participant's Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Van Oostveen Medical B.V.
- 9.4.6.1. Participant's Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Teleflex Incorporated
- 9.4.7.1. Participant's Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Convatec
- 9.4.8.1. Participant's Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Fuji Systems Corp
- 9.4.9.1. Participant's Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. SEWOON MEDICAL Co., Ltd.
- 9.4.10.1. Participant's Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.11. Mercury Medical
- 9.4.11.1. Participant's Overview
- 9.4.11.2. Financial Performance
- 9.4.11.3. Product Benchmarking
- 9.4.11.4. Recent Developments/ Strategic Initiatives
- 9.4.12. Hollister Incorporated
- 9.4.12.1. Participant's Overview
- 9.4.12.2. Financial Performance
- 9.4.12.3. Product Benchmarking
- 9.4.12.4. Recent Developments/ Strategic Initiatives
- 9.4.13. Well Lead Medical Co., Ltd
- 9.4.13.1. Participant's Overview
- 9.4.13.2. Financial Performance
- 9.4.13.3. Product Benchmarking
- 9.4.13.4. Recent Developments/ Strategic Initiatives
- 9.4.14. Viggo Medical Devices
- 9.4.14.1. Participant's Overview
- 9.4.14.2. Financial Performance
- 9.4.14.3. Product Benchmarking
- 9.4.14.4. Recent Developments/ Strategic Initiatives
- 9.4.15. ARMSTRONG MEDICAL
- 9.4.15.1. Participant's Overview
- 9.4.15.2. Financial Performance
- 9.4.15.3. Product Benchmarking
- 9.4.15.4. Recent Developments/ Strategic Initiatives
- 9.4.16. Medline
- 9.4.16.1. Participant's Overview
- 9.4.16.2. Financial Performance
- 9.4.16.3. Product Benchmarking
- 9.4.16.4. Recent Developments/ Strategic Initiatives
- 9.4.17. BD (BESDATA)
- 9.4.17.1. Participant's Overview
- 9.4.17.2. Financial Performance
- 9.4.17.3. Product Benchmarking
- 9.4.17.4. Recent Developments/ Strategic Initiatives
- 9.4.18. BRIO DEVICE, LLC.
- 9.4.18.1. Participant's Overview
- 9.4.18.2. Financial Performance
- 9.4.18.3. Product Benchmarking
- 9.4.18.4. Recent Developments/ Strategic Initiatives
- 9.4.19. pfm medical ag
- 9.4.19.1. Participant's Overview
- 9.4.19.2. Financial Performance
- 9.4.19.3. Product Benchmarking
- 9.4.19.4. Recent Developments/ Strategic Initiatives